Portfolio Lab

DENTSPLY SIRONA Inc.

  • Stock
  • Ticker XRAY
  • ISIN US24906P1093
  • Nasdaq

Health care · Medical technology · USA

$8.29 −2.36%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of DENTSPLY SIRONA Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

XRAYGlobal equities (VT)

$10,000 grew to $1,593. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −86.6% in 11/2026, measured from the peak in 05/2021. The old peak has not been reached again yet.

1-year return
−15.0%
5-year return p.a.
−29.5%
10-year return p.a.
−16.8%
Volatility p.a.
32.3%
Largest decline
−86.6%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue905879936904961880898836
Gross profit446466490441443427493443
Operating income-50963-128-218-139-358237
EBITDA-421142-40-126-4644167119
Net income-43020-45-427-146-1037-2.0
Earnings per share-2.130.10-0.22-2.14-0.73-0.050.18-0.01
Balance sheet
Total assets5,7536,0506,0695,6535,4295,2295,2045,190
Liabilities3,8104,0404,1084,1754,0893,9103,8533,836
Equity1,9422,0101,9601,4781,3391,3181,3511,355
Cash272398359363326190239195
Long-term debt1,5861,5932,2182,0172,0152,0061,9961,985
Cash flow
Operating cash flow877.04879101409932
Capital expenditure-51-19-32-39-41-52-44-32
Free cash flow36-12164060-12550.0

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2019 at +53.1%, weakest 2024 at −45.3%. 4 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
5 Nov 2026−$0.01
6 Aug 2026$0.18
5 May 2026−$0.05
26 Feb 2026−$0.73
6 Nov 2025−$2.14
7 Aug 2025−$0.22
8 May 2025$0.10
27 Feb 2025−$2.13
7 Nov 2024−$2.46
31 Jul 2024−$0.02
2 May 2024$0.09
29 Feb 2024$0.32

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€1.5bn
Market cap in trading currency
$1.64bn
Enterprise value
$3.65bn
P/E
–
P/S
0.46
P/B
1.21
EV/Sales
1.02
EV/EBITDA
12.8
Earnings yield
–
FCF yield
6.3%

Results (last four quarters)

Revenue
$3.58bn
Gross profit
$1.81bn
EBITDA
$284m
Net income
−$121m
Earnings per share
−$0.61
Revenue per share
$18.04
Revenue growth
−7.5%
Earnings growth
–

Profitability

Gross margin
50.5%
Operating margin
-1.5%
Net margin
-3.4%
Return on equity
-8.5%
Return on assets
-2.3%

Balance sheet and cash flow

Cash
$195m
Cash per share
$0.98
Financial debt
$2.20bn
Debt/equity %
162
Current ratio
1.63
Book value per share
$6.84
Operating cash flow
$272m
Free cash flow
$103m

Dividend

Dividend yield
1.93%
Dividend (12 months)
$0.16
Yield (12 months)
1.93%
Payout ratio
–
Ex-dividend date
26 Dec 2025

Shares and trading

Shares outstanding
198m
Volume
4.88m
Avg. volume 3 months
4.69m
Relative volume
1.0

Price and technicals

Price
$8.29
1 day
−2.4%
52-week high
$14.68
52-week low
$8.29
Distance to 52-week high
−43.5%
Distance to 52-week low
0.0%
Distance to 50-day line
−10.0%
Distance to 200-day line
−25.3%
RSI (14)
35
Volatility 1M
54.5%

Performance

1 week
−9.5%
1 month
−12.7%
3 months
−23.9%
6 months
−18.8%
YTD
−27.5%
1 year
−17.8%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has XRAY performed since 11/2016?

$10,000 grew to $1,593 by 20 Nov 2026, which is −16.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is XRAY?

Volatility was 32.3% per year, measured on monthly returns. The largest decline from a peak was −86.6%, with the low in 11/2026.

How does XRAY compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, XRAY returned −16.8% at 32.3%. The correlation of monthly returns was 0.49; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

DENTSPLY SIRONA Inc. (XRAY): Return and risk | Portfolio Lab